All Stories

  1. Evidence Generation for a Host-Response Biosignature of Respiratory Disease

    Article • Viruses, July 2025, MDPI AG

    Dr Stuart C. Ray

  2. Lens Free Holographic Imaging for Urinary Tract Infection Screening

    Article • IEEE Transactions on Biomedical Engineering, March 2023, Institute of Electrical & Electronics Engineers (IEEE)

    Dr Stuart C. Ray

  3. Factors associated with resistance to SARS-CoV-2 infection discovered using large-scale medical record data and machine learning

    Article • PLOS One, February 2023, PLOS

    Dr Stuart C. Ray

  4. Assessing Associations Between COVID-19 Symptomology and Adverse Outcomes After Piloting Crowdsourced Data Collection: Cross-sectional Survey Study

    Article • JMIR Formative Research, December 2022, JMIR Publications Inc.

    Dr Stuart C. Ray

  5. Closing the Brief Case: The Fly Who Cried Wohlf

    Article • Journal of Clinical Microbiology, June 2022, ASM Journals

    Dr Stuart C. Ray

  6. The Brief Case: The Fly Who Cried Wohlf

    Article • Journal of Clinical Microbiology, June 2022, ASM Journals

    Dr Stuart C. Ray

  7. Severe acute respiratory coronavirus virus 2 (SARS-CoV-2) exposure investigations using genomic sequencing among healthcare workers and patients in a large academic center

    Article • Infection Control, March 2022, Cambridge University Press

    Dr Stuart C. Ray

  8. B cell overexpression of FCRL5 and PD-1 is associated with low antibody titers in HCV infection

    Article • PLoS Pathogens, January 2022, PLOS

    Dr James E Crowe, Dr Stuart C. Ray

  9. Decreased Activated CD4+T Cell Repertoire Diversity After Antiretroviral Therapy in HIV-1/HCV Coinfection Correlates with CD4+T Cell Recovery

    Article • Viral Immunology, November 2021, Mary Ann Liebert Inc

    Dr Stuart C. Ray

  10. Convergent antibody responses associated with broad neutralization of hepatitis C virus and clearance of infection

    Article • September 2021, Cold Spring Harbor Laboratory Press

    Dr Stuart C. Ray

  11. Spatiotemporal Phylodynamics of Hepatitis C Among People Who Inject Drugs in India

    Article • Hepatology, August 2021, Wolters Kluwer Health

    Dr Stuart C. Ray

  12. No evidence of SARS-CoV-2 reverse transcription and integration as the origin of chimeric transcripts in patient tissues

    Article • Proceedings of the National Academy of Sciences, August 2021, Proceedings of the National Academy of Sciences

    Dr Stuart C. Ray, Dr Robert Gifford

  13. Interleukin‐18 and tumor necrosis factor‐α are elevated in solid organ transplant recipients with possible cytomegalovirus end‐organ disease

    Article • Transplant Infectious Disease, July 2021, Wiley

    Dr Stuart C. Ray

  14. Drivers and barriers to workplace-based HIV self-testing among high-risk men in Uganda: a qualitative study

    Article • BMC Public Health, May 2021, Springer Science + Business Media

    Dr Stuart C. Ray

  15. Durable SARS-CoV-2 B cell immunity after mild or severe disease

    Article • Journal of Clinical Investigation, April 2021, American Society for Clinical Investigation

    Dr Stuart C. Ray

  16. Genomic diversity of SARS-CoV-2 during early introduction into the Baltimore–Washington metropolitan area

    Article • JCI Insight, March 2021, American Society for Clinical Investigation

    Dr Stuart C. Ray

  17. Healthy donor T cell responses to common cold coronaviruses and SARS-CoV-2

    Article • Journal of Clinical Investigation, November 2020, American Society for Clinical Investigation

    Dr Stuart C. Ray

  18. Factors associated with phylogenetic clustering of hepatitis C among people who inject drugs in Baltimore

    Article • BMC Infectious Diseases, November 2020, Springer Science + Business Media

    Dr Stuart C. Ray

  19. Durable SARS-CoV-2 B cell immunity after mild or severe disease

    Article • October 2020, Cold Spring Harbor Laboratory Press

    Dr Stuart C. Ray

  20. IgM autoantibodies recognizing ACE2 are associated with severe COVID-19

    Article • October 2020, Cold Spring Harbor Laboratory Press

    Dr Stuart C. Ray

  21. Genomic Diversity of SARS-CoV-2 During Early Introduction into the United States National Capital Region

    Article • August 2020, Cold Spring Harbor Laboratory Press

    Dr Stuart C. Ray

  22. Generative optical modeling of whole blood for detecting platelets in lens-free images

    Article • Biomedical Optics Express, March 2020, Optical Society of America (OSA)

    Dr Stuart C. Ray

  23. Correlates of hepatitis C viral clustering among people who inject drugs in Baltimore

    Article • Infection Genetics and Evolution, January 2020, Elsevier

    Dr Stuart C. Ray

  24. Diversity of hepatitis C virus infection among HIV-infected people who inject drugs in India

    Article • VirusDisease, December 2019, Springer Science + Business Media

    Dr Stuart C. Ray

  25. Plasma deconvolution identifies broadly neutralizing antibodies associated with hepatitis C virus clearance

    Article • Journal of Clinical Investigation, August 2019, American Society for Clinical Investigation

    Dr James E Crowe, Dr Stuart C. Ray

  26. Inconsistent temporal patterns of genetic variation of HCV among high-risk subjects may impact inference of transmission networks

    Article • Infection Genetics and Evolution, July 2019, Elsevier

    Dr Stuart C. Ray

  27. Users beware! Biological variation in complete blood counts over short time intervals

    Article • BMJ evidence-based medicine, May 2019, BMJ

    Dr Stuart C. Ray

  28. Building Leadership Capacity for Mission Execution in a Large Academic Department of Medicine

    Article • The American Journal of Medicine, April 2019, Elsevier

    Dr Stuart C. Ray

  29. Joint Holographic Detection and Reconstruction

    Article • January 2019, Springer Science + Business Media

    Dr Stuart C. Ray

  30. An Optical Model of Whole Blood for Detecting Platelets in Lens-Free Images

    Article • January 2019, Springer Science + Business Media

    Dr Stuart C. Ray

  31. Broadly Neutralizing Antibody Mediated Clearance of Human Hepatitis C Virus Infection

    Article • Cell Host & Microbe, November 2018, Elsevier

    Dr Stuart C. Ray, Dr James E Crowe

  32. CMPK2 and BCL-G are associated with type 1 interferon–induced HIV restriction in humans

    Article • Science Advances, August 2018, American Association for the Advancement of Science

    Dr Stuart C. Ray

  33. Impact of Point-of-Care Diagnostics on Clinical Decision-making in Low- and Middle-Income Countries

    Article • The Journal of Applied Laboratory Medicine, June 2018, AACC

    Dr Stuart C. Ray

  34. Complex patterns of Hepatitis-C virus longitudinal clustering in a high-risk population

    Article • Infection Genetics and Evolution, March 2018, Elsevier

    Dr Stuart C. Ray

  35. Expanded cellular clones carrying replication-competent HIV-1 persist, wax, and wane

    Article • Proceedings of the National Academy of Sciences, February 2018, Proceedings of the National Academy of Sciences

    Dr Stuart C. Ray

  36. Rapid and sensitive detection of viral nucleic acids using silicon microchips

    Article • The Analyst, January 2018, Royal Society of Chemistry

    Dr Stuart C. Ray

  37. Synergistic anti-HCV broadly neutralizing human monoclonal antibodies with independent mechanisms

    Article • Proceedings of the National Academy of Sciences, December 2017, Proceedings of the National Academy of Sciences

    Dr James E Crowe, Dr Stuart C. Ray

  38. New Therapies for Treating Hepatitis C Virus: Impact on Laboratory Testing Recommendations and Clinical Management

    Article • Clinical Chemistry, October 2017, AACC

    Dr Stuart C. Ray, Nicole Tolan

  39. Intracellular HIV-1 RNA and CD4+ T-cell activation in patients starting antiretrovirals

    Article • AIDS, June 2017, Wolters Kluwer Health

    Dr Stuart C. Ray

  40. It’s 10 pm ; Do You Know Where Your Data Are?

    Article • Circulation Research, May 2017, Wolters Kluwer Health

    Dr Stuart C. Ray

  41. Broadly neutralizing antibodies with few somatic mutations and hepatitis C virus clearance

    Article • JCI Insight, May 2017, American Society for Clinical Investigation

    Dr Stuart C. Ray, Dr James E Crowe

  42. Extra-epitopic hepatitis C virus polymorphisms confer resistance to broadly neutralizing antibodies by modulating binding to scavenger receptor B1

    Article • PLoS Pathogens, February 2017, PLOS

    Dr Stuart C. Ray

  43. Hepatitis C virus resistance to broadly neutralizing antibodies measured using replication-competent virus and pseudoparticles

    Article • Journal of General Virology, November 2016, Society for General Microbiology

    Dr Stuart C. Ray

  44. A Hepatitis C Virus Envelope Polymorphism Confers Resistance to Neutralization by Polyclonal Sera and Broadly Neutralizing Monoclonal Antibodies

    Article • Journal of Virology, January 2016, ASM Journals

    Dr Stuart C. Ray

  45. Acute Hepatitis C Virus Infection Induces Consistent Changes in Circulating MicroRNAs That Are Associated with Nonlytic Hepatocyte Release

    Article • Journal of Virology, July 2015, ASM Journals

    Dr. Kenneth W Witwer, Dr Stuart C. Ray

  46. Global Diversity within and between Human Herpesvirus 1 and 2 Glycoproteins

    Article • Journal of Virology, May 2015, ASM Journals

    Susanna Lamers, Dr Stuart C. Ray

  47. Genome Sequencing and Analysis of Geographically Diverse Clinical Isolates of Herpes Simplex Virus 2

    Article • Journal of Virology, May 2015, ASM Journals

    Dr Ruchi M Newman, Dr Stuart C. Ray

  48. CD4+T-Cell–Dependent Reduction in Hepatitis C Virus–Specific Neutralizing Antibody Responses After Coinfection With Human Immunodeficiency Virus

    Article • The Journal of Infectious Diseases, March 2015, Oxford University Press (OUP)

    Dr Stuart C. Ray

  49. Hepatitis C

    Article • January 2015, Elsevier

    Dr Stuart C. Ray

  50. Naturally selected hepatitis C virus polymorphisms confer broad neutralizing antibody resistance

    Article • Journal of Clinical Investigation, December 2014, American Society for Clinical Investigation

    Dr Stuart C. Ray

  51. Inferring Viral Dynamics in Chronically HCV Infected Patients from the Spatial Distribution of Infected Hepatocytes

    Article • PLoS Computational Biology, November 2014, PLOS

    Dr Stuart C. Ray

  52. Interferon-free treatment of chronic hepatitis C with faldaprevir, deleobuvir and ribavirin: SOUND-C3, a Phase 2b study

    Article • Liver International, October 2014, Wiley

    Dr Stuart C. Ray, Dr. Vicente Soriano

  53. Antiretroviral therapy, interferon sensitivity, and virologic setpoint in human immunodeficiency virus/hepatitis C virus coinfected patients

    Article • Hepatology, August 2014, Wolters Kluwer Health

    Dr Stuart C. Ray

  54. Clearance of hepatitis C infection is associated with the early appearance of broad neutralizing antibody responses

    Article • Hepatology, June 2014, Wolters Kluwer Health

    Dr Stuart C. Ray

  55. Accelerating Drug Development Through Collaboration: The Hepatitis C Drug Development Advisory Group

    Article • Clinical Pharmacology & Therapeutics, May 2014, Springer Science + Business Media

    Dr Stuart C. Ray

  56. The Role of Viral Introductions in Sustaining Community-Based HIV Epidemics in Rural Uganda: Evidence from Spatial Clustering, Phylogenetics, and Egocentric Transmission Models

    Article • PLoS Medicine, March 2014, PLOS

    Dr Stuart C. Ray

  57. Use of Laser Capture Microdissection to Map Hepatitis C Virus–Positive Hepatocytes in Human Liver

    Article • Gastroenterology, December 2013, Elsevier

    Dr Stuart C. Ray

  58. Molecular epidemiology of GB type C virus among individuals exposed to hepatitis C virus in Cameroon

    Article • Microbiology Research, April 2013, PAGEPress Publications

    Dr Stuart C. Ray

  59. Single Cell Laser Capture Microdissection Reveals the Hepatitis C Viral Landscape in the Human Liver

    Article • December 2012, Office of Scientific and Technical Information (OSTI)

    Dr Stuart C. Ray

  60. Recommendations for standardized nomenclature and definitions of viral response in trials of hepatitis C virus investigational agents

    Article • Hepatology, December 2012, Wiley

    Dr Stuart C. Ray

  61. Constraints on Viral Evolution during Chronic Hepatitis C Virus Infection Arising from a Common-Source Exposure

    Article • Journal of Virology, September 2012, ASM Journals

    Dr Stuart C. Ray

  62. Laser captured hepatocytes show association of butyrylcholinesterase gene loss and fibrosis progression in hepatitis C-infected drug users

    Article • Hepatology, August 2012, Wolters Kluwer Health

    Dr Stuart C. Ray

  63. Spontaneous clearance of primary acute hepatitis C virus infection correlated with high initial viral RNA level and rapid HVR1 evolution

    Article • Hepatology, June 2012, Wolters Kluwer Health

    Dr Stuart C. Ray

  64. Immunogenicity and Cross-Reactivity of a Representative Ancestral Sequence in Hepatitis C Virus Infection

    Article • The Journal of Immunology, April 2012, The American Association of Immunologists

    Dr Stuart C. Ray

  65. Computational Reconstruction of Bole1a, a Representative Synthetic Hepatitis C Virus Subtype 1a Genome

    Article • Journal of Virology, March 2012, ASM Journals

    Dr Stuart C. Ray

  66. Hepatitis C virus epitope exposure and neutralization by antibodies is affected by time and temperature

    Article • Virology, January 2012, Elsevier

    Dr Stuart C. Ray

  67. Analysis of Genetic Linkage of HIV From Couples Enrolled in the HIV Prevention Trials Network 052 Trial

    Article • The Journal of Infectious Diseases, October 2011, Oxford University Press (OUP)

    Dr Stuart C. Ray

  68. The transhepatic endotoxin gradient is present despite liver cirrhosis and is attenuated after transjugular portosystemic shunt (TIPS).

    Article • BMC Gastroenterology, October 2011, Springer Science + Business Media

    Dr Stuart C. Ray

  69. Molecular Epidemiology of HIV Type 1 in Singapore and Identification of Novel CRF01_AE/B Recombinant Forms

    Article • AIDS Research and Human Retroviruses, October 2011, Mary Ann Liebert Inc

    Dr Stuart C. Ray

  70. A 61 year-old Female with a Prior History of Tuberculosis Presenting with Hemoptysis

    Article • Clinical Infectious Diseases, March 2011, Oxford University Press (OUP)

    Dr Stuart C. Ray

  71. A 61-Year-Old Female with a Prior History of Tuberculosis Presenting with Hemoptysis

    Article • Clinical Infectious Diseases, March 2011, Oxford University Press (OUP)

    Dr Stuart C. Ray

  72. Protective interleukin-28B genotype affects hepatitis C virus clearance, but does not contribute to HIV-1 control in a cohort of African–American elite controllers/suppressors

    Article • AIDS, January 2011, Wolters Kluwer Health

    Dr Stuart C. Ray

  73. Evolution of the HIV-1 nefgene in HLA-B*57 Positive Elite Suppressors

    Article • Retrovirology, November 2010, Springer Science + Business Media

    Dr Stuart C. Ray

  74. Hepatitis C Virus Infection of Neuroepithelioma Cell Lines

    Article • Gastroenterology, October 2010, Elsevier

    Dr Stuart C. Ray, Johan Neyts

  75. Analysis of HIV Diversity Using a High-Resolution Melting Assay

    Article • AIDS Research and Human Retroviruses, August 2010, Mary Ann Liebert Inc

    Dr Stuart C. Ray

  76. Control of HIV-1 in Elite Suppressors despite Ongoing Replication and Evolution in Plasma Virus

    Article • Journal of Virology, May 2010, ASM Journals

    Dr Stuart C. Ray

  77. Acceleration of Hepatitis C Virus Envelope Evolution in Humans Is Consistent with Progressive Humoral Immune Selection during the Transition from Acute to Chronic Infection

    Article • Journal of Virology, March 2010, ASM Journals

    Dr Stuart C. Ray

  78. Genetic Linkage of Hepatitis B Virus in Peripheral Blood Leukocytes Provides Evidence for Contamination

    Article • Journal of Virology, January 2010, ASM Journals

    Dr Stuart C. Ray

  79. Spontaneous Control of Primary Hepatitis C Virus Infection and Immunity Against Persistent Reinfection

    Article • Gastroenterology, January 2010, Elsevier

    Dr Stuart C. Ray

  80. Hepatitis C

    Article • January 2010, Elsevier

    Dr Stuart C. Ray

  81. HIV‐1 Evolution Following Transmission to an HLA‐B*5801‐Positive Patient

    Article • The Journal of Infectious Diseases, December 2009, Oxford University Press (OUP)

    Dr Stuart C. Ray

  82. Kupffer cells are depleted with HIV immunodeficiency and partially recovered with antiretroviral immune reconstitution

    Article • AIDS, November 2009, Wolters Kluwer Health

    Dr Stuart C. Ray

  83. High diversity of hepatitis C viral quasispecies is associated with early virological response in patients undergoing antiviral therapy

    Article • Hepatology, September 2009, Wiley

    Dr Stuart C. Ray

  84. Identification of Ongoing Human Immunodeficiency Virus Type 1 (HIV-1) Replication in Residual Viremia during Recombinant HIV-1 Poxvirus Immunizations in Patients with Clinically Undetectable Viral Loads on Durable Suppressive Highly Active Antiretrovir...

    Article • Journal of Virology, July 2009, ASM Journals

    Dr Stuart C. Ray

  85. Selection Pressure From Neutralizing Antibodies Drives Sequence Evolution During Acute Infection With Hepatitis C Virus

    Article • Gastroenterology, June 2009, Elsevier

    Dr Stuart C. Ray

  86. Identification of Nevirapine‐Resistant HIV‐1 in the Latent Reservoir after Single‐Dose Nevirapine to Prevent Mother‐to‐Child Transmission of HIV‐1

    Article • The Journal of Infectious Diseases, May 2009, Oxford University Press (OUP)

    Dr Stuart C. Ray

  87. High-Programmed Death-1 Levels on Hepatitis C Virus-Specific T Cells during Acute Infection Are Associated with Viral Persistence and Require Preservation of Cognate Antigen during Chronic Infection

    Article • The Journal of Immunology, December 2008, The American Association of Immunologists

    Dr Stuart C. Ray

  88. Maternal Neutralizing Antibody and Transmission of Hepatitis C Virus to Infants

    Article • The Journal of Infectious Diseases, December 2008, Oxford University Press (OUP)

    Dr Stuart C. Ray

  89. Hepatitis C Virus Immune Escape via Exploitation of a Hole in the T Cell Repertoire

    Article • The Journal of Immunology, October 2008, The American Association of Immunologists

    Dr Stuart C. Ray

  90. Genetic Divergence of Hepatitis C Virus: The Role of HIV-Related Immunosuppression

    Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, October 2008, Wolters Kluwer Health

    Dr Stuart C. Ray

  91. Human Immunodeficiency Virus-Related Microbial Translocation and Progression of Hepatitis C

    Article • Gastroenterology, July 2008, Elsevier

    Dr Stuart C. Ray

  92. Acute hepatitis C

    Article • The Lancet, July 2008, Elsevier

    Dr Stuart C. Ray

  93. Analyses of HIV-1 Drug-Resistance Profiles Among Infected Adolescents Experiencing Delayed Antiretroviral Treatment Switch After Initial Nonsuppressive Highly Active Antiretroviral Therapy

    Article • AIDS Patient Care and STDs, July 2008, Mary Ann Liebert Inc

    Dr Stuart C. Ray

  94. Transmission of Human Immunodeficiency Virus Type 1 from a Patient Who Developed AIDS to an Elite Suppressor

    Article • Journal of Virology, May 2008, ASM Journals

    Dr Stuart C. Ray

  95. Comprehensive Genetic and Epigenetic Analysis of Occult Hepatitis B from Liver Tissue Samples

    Article • Clinical Infectious Diseases, April 2008, Oxford University Press (OUP)

    Dr Stuart C. Ray

  96. CD4+T Cell Depletion in an Untreated HIV Type 1–Infected Human Leukocyte Antigen–B*5801–Positive Patient with an Undetectable Viral Load

    Article • Clinical Infectious Diseases, April 2008, Oxford University Press (OUP)

    Dr Stuart C. Ray

  97. Early Archiving and Predominance of Nonnucleoside Reverse Transcriptase Inhibitor–Resistant HIV‐1 among Recently Infected Infants Born in the United States

    Article • The Journal of Infectious Diseases, May 2007, Oxford University Press (OUP)

    Dr Stuart C. Ray

  98. CD4 + T Cell–Dependent Reduction in Hepatitis C Virus–Specific Humoral Immune Responses after HIV Infection

    Article • The Journal of Infectious Diseases, March 2007, Oxford University Press (OUP)

    Dr Stuart C. Ray

  99. Slow Human Immunodeficiency Virus Type 1 Evolution in Viral Reservoirs in Infants Treated with Effective Antiretroviral Therapy

    Article • AIDS Research and Human Retroviruses, March 2007, Mary Ann Liebert Inc

    Dr Stuart C. Ray

  100. Progression of Fibrosis during Chronic Hepatitis C Is Associated with Rapid Virus Evolution

    Article • Journal of Virology, February 2007, ASM Journals

    Dr Stuart C. Ray

  101. A sensitive genotyping assay for detection of drug resistance mutations in reverse transcriptase of HIV-1 subtypes B and C in samples stored as dried blood spots or frozen RNA extracts

    Article • Journal of Virological Methods, September 2006, Elsevier

    Dr Stuart C. Ray

  102. Residual Human Immunodeficiency Virus Type 1 Viremia in Some Patients on Antiretroviral Therapy Is Dominated by a Small Number of Invariant Clones Rarely Found in Circulating CD4+ T Cells

    Article • Journal of Virology, July 2006, ASM Journals

    Dr Stuart C. Ray

  103. Neutralizing Antibodies Do Not Mediate Suppression of Human Immunodeficiency Virus Type 1 in Elite Suppressors or Selection of Plasma Virus Variants in Patients on Highly Active Antiretroviral Therapy

    Article • Journal of Virology, May 2006, ASM Journals

    Dr Stuart C. Ray

  104. Humoral Immune Response in Acute Hepatitis C Virus Infection

    Article • Clinical Infectious Diseases, September 2005, Oxford University Press (OUP)

    Dr Stuart C. Ray

  105. Comprehensive Analyses of CD8+ T Cell Responses During Longitudinal Study of Acute Human Hepatitis C *

    Article • Hepatology, July 2005, Wolters Kluwer Health

    Dr Stuart C. Ray

  106. Cellular immune selection with hepatitis C virus persistence in humans

    Article • Journal of Experimental Medicine, June 2005, Rockefeller University Press

    Dr Stuart C. Ray

  107. Divergent and convergent evolution after a common-source outbreak of hepatitis C virus

    Article • Journal of Experimental Medicine, June 2005, Rockefeller University Press

    Dr Stuart C. Ray

  108. A Novel Assay Allows Genotyping of the Latent Reservoir for Human Immunodeficiency Virus Type 1 in the Resting CD4+ T Cells of Viremic Patients

    Article • Journal of Virology, April 2005, ASM Journals

    Dr Stuart C. Ray

  109. Prospective Evaluation of Community‐Acquired Acute‐Phase Hepatitis C Virus Infection

    Article • Clinical Infectious Diseases, April 2005, Oxford University Press (OUP)

    Dr Stuart C. Ray

  110. Intermittent HIV-1 Viremia (Blips) and Drug Resistance in Patients Receiving HAART

    Article • JAMA, February 2005, American Medical Association (AMA)

    Dr Stuart C. Ray

  111. Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF

    Article • Proceedings of the National Academy of Sciences, February 2005, Proceedings of the National Academy of Sciences

    Dr Stuart C. Ray

  112. G→A Hypermutation in Protease and Reverse Transcriptase Regions of Human Immunodeficiency Virus Type 1 Residing in Resting CD4+ T Cells In Vivo

    Article • Journal of Virology, February 2005, ASM Journals

    Dr Stuart C. Ray

  113. Accurate Representation of the Hepatitis C Virus Quasispecies in 5.2-Kilobase Amplicons

    Article • Journal of Clinical Microbiology, September 2004, ASM Journals

    Dr Stuart C. Ray

  114. Genotypic Analysis of HIV‐1 Drug Resistance at the Limit of Detection: Virus Production without Evolution in Treated Adults with Undetectable HIV Loads

    Article • The Journal of Infectious Diseases, April 2004, Oxford University Press (OUP)

    Dr Stuart C. Ray

  115. Cross-Genotype Immunity to Hepatitis C Virus

    Article • Journal of Virology, February 2004, ASM Journals

    Dr Stuart C. Ray

  116. Continued Production of Drug-Sensitive Human Immunodeficiency Virus Type 1 in Children on Combination Antiretroviral Therapy Who Have Undetectable Viral Loads

    Article • Journal of Virology, January 2004, ASM Journals

    Dr Stuart C. Ray

  117. Characterization of novel recombinant HIV-1 genomes using the branching index

    Article • Virology, November 2003, Elsevier

    Dr Stuart C. Ray

  118. Persistence of Wild-Type Virus and Lack of Temporal Structure in the Latent Reservoir for Human Immunodeficiency Virus Type 1 in Pediatric Patients with Extensive Antiretroviral Exposure

    Article • Journal of Virology, September 2002, ASM Journals

    Dr Stuart C. Ray

  119. Immunity against hepatitis C virus infection

    Article • The Lancet, September 2002, Elsevier

    Dr Stuart C. Ray

  120. Needlestick Transmission of Hepatitis C

    Article • JAMA, May 2002, American Medical Association (AMA)

    Dr Stuart C. Ray

  121. Protection against persistence of hepatitis C

    Article • The Lancet, April 2002, Elsevier

    Dr Stuart C. Ray

  122. Dynamics of SEN Virus Infection among Injection Drug Users

    Article • The Journal of Infectious Diseases, November 2001, Oxford University Press (OUP)

    Dr Stuart C. Ray

  123. Determinants of Viral Clearance and Persistence during Acute Hepatitis C Virus Infection

    Article • Journal of Experimental Medicine, November 2001, Rockefeller University Press

    Dr Stuart C. Ray

  124. Reorganization of genera in the families Rickettsiaceae and Anaplasmataceae in the order Rickettsiales: unification of some species of Ehrlichia with Anaplasma, Cowdria with Ehrlichia and Ehrlichia with Neorickettsia, descriptions of six new species co...

    Article • INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY, November 2001, Society for General Microbiology

    Dr Stuart C. Ray

  125. HIV-1 Drug Resistance Profiles in Children and Adults With Viral Load of <50 Copies/mL Receiving Combination Therapy

    Article • JAMA, July 2001, American Medical Association (AMA)

    Dr Stuart C. Ray

  126. Human Immunodeficiency Virus Seroconversion and Evolution of the Hepatitis C Virus Quasispecies

    Article • Journal of Virology, April 2001, ASM Journals

    Dr Stuart C. Ray

  127. Prospective Characterization of Full-Length Hepatitis C Virus NS5A Quasispecies during Induction and Combination Antiviral Therapy

    Article • Journal of Virology, October 2000, ASM Journals

    Dr Stuart C. Ray

  128. Genetic Epidemiology of Hepatitis C Virus throughout Egypt

    Article • The Journal of Infectious Diseases, September 2000, Oxford University Press (OUP)

    Dr Stuart C. Ray

  129. A stable latent reservoir for HIV-1 in resting CD4+ T lymphocytes in infected children

    Article • Journal of Clinical Investigation, April 2000, American Society for Clinical Investigation

    Dr Stuart C. Ray

  130. Hypervariable Region 1 Sequence Stability during Hepatitis C Virus Replication in Chimpanzees

    Article • Journal of Virology, April 2000, ASM Journals

    Dr Stuart C. Ray

  131. Determinants of the Quantity of Hepatitis C Virus RNA

    Article • The Journal of Infectious Diseases, March 2000, Oxford University Press (OUP)

    Dr Stuart C. Ray

  132. Sex and the genetic diversity of HIV-1

    Article • Nature Medicine, January 2000, Springer Science + Business Media

    Dr Stuart C. Ray

  133. Prevalence of Congenital Homocystinuria in Denmark

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, May 1999, New England Journal of Medicine (NEJM/MMS)

    Dr Stuart C. Ray

  134. Recrudescence of Treated Neurosyphilis in a Patient With Human Immunodeficiency Virus

    Article • Mayo Clinic Proceedings, January 1999, Elsevier

    Dr Stuart C. Ray

  135. Autologous Strain-Specific Cytolytic T Lymphocyte Responses Directed against Human Immunodeficiency Virus Type 1 Env

    Article • AIDS Research and Human Retroviruses, January 1998, Mary Ann Liebert Inc

    Dr Stuart C. Ray

  136. Characterization of a Polyclonal Cytolytic T Lymphocyte Response to Human Immunodeficiency Virus in Persons without Clinical Progression

    Article • The Journal of Infectious Diseases, June 1997, Oxford University Press (OUP)

    Dr Stuart C. Ray

  137. Ecchymoses and eschars at sites of injection

    Article • The Lancet, May 1997, Elsevier

    Dr Stuart C. Ray

  138. Volatilization of mercury from natural water by a broad-spectrum Hg-resistantBacillus pasteurii strain DR2

    Article • The Environmentalist, September 1996, Springer Science + Business Media

    Dr Stuart C. Ray

  139. Oral antibiotic treatment of right-sided staphylococcal endocarditis in injection drug users: Prospective randomized comparison with parenteral therapy

    Article • The American Journal of Medicine, July 1996, Elsevier

    Dr Stuart C. Ray

  140. Predominance of defective proviral sequences in an HIV + long-term non-progressor

    Article • Immunology Letters, June 1996, Elsevier

    Dr Stuart C. Ray

  141. Human Immunodeficiency Virus Type 1 env and p17gag Sequence Variation in Polymerase Chain Reaction-Positive, Seronegative Injection Drug Users

    Article • The Journal of Infectious Diseases, April 1995, Oxford University Press (OUP)

    Dr Stuart C. Ray

  142. Presence in India of HIV Type 1 Similar to North American Strains

    Article • AIDS Research and Human Retroviruses, August 1994, Mary Ann Liebert Inc

    Dr Stuart C. Ray

  143. Eukaryotic start and stop translation sites

    Article • Nucleic Acids Research, January 1991, Oxford University Press (OUP)

    Dr Stuart C. Ray

  144. Monomer sequence determination of carbohydrates using fast-atom bombardment mass spectrometry of periodate-oxidized acetate ester derivatives

    Article • Carbohydrate Research, March 1990, Elsevier

    Dr Stuart C. Ray